Key facts
- It has raised $1.7M; the latest was Later Stage VC in Mar 2025.
- Notable investors include Hong Kong Science & Technology Parks, Guangzhou Doppler Electronic Technology, The Hong Kong Polytechnic University.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Eieling Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Eieling Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eieling Technology
Developer of medical ultrasound equipment designed to assess liver fibrosis and fatty liver. The company utilizes transient elastography and real-time B-ultrasound imaging technology to enable early detection and continuous monitoring of liver health, supporting healthcare providers in accurately diagnosing and managing chronic liver diseases while improving patient care and treatment outcomes.
- Sector
- Healthcare
- HQ
- Hong Kong
- Founded
- 2018
- Website
- eieling.com/
- Ownership
- Privately Held (backing)
Eieling Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eieling Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eieling Technology in its N-PORT filings yet. We sweep new filings monthly.